Venturi Wealth Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.48K Hold
10,500
﹤0.01% 630
2026
Q1
$8.4K Hold
10,500
﹤0.01% 602
2025
Q4
$13.7K Hold
10,500
﹤0.01% 582
2025
Q3
$13.2K Hold
10,500
﹤0.01% 565
2025
Q2
$21.7K Hold
10,500
﹤0.01% 534
2025
Q1
$23.1K Hold
10,500
﹤0.01% 555
2024
Q4
$16.1K Hold
10,500
﹤0.01% 1319
2024
Q3
$20.9K Hold
10,500
﹤0.01% 1004
2024
Q2
$36.8K Hold
10,500
﹤0.01% 766
2024
Q1
$29.1K Hold
10,500
﹤0.01% 633
2023
Q4
$17.9K Hold
10,500
﹤0.01% 729
2023
Q3
$10.8K Sell
10,500
-290
-3% -$413 ﹤0.01% 793
2023
Q2
$12.5K Hold
10,790
﹤0.01% 625
2023
Q1
$16.3K Buy
10,790
+290
+3% +$726 ﹤0.01% 632
2022
Q4
$26.3K Buy
+10,500
New +$33.8K ﹤0.01% 324
2019
Q2
Sell
-10,585
Closed -$260K 249
2019
Q1
$260K Sell
10,585
-5
-0% -$131 0.03% 219
2018
Q4
$276K Buy
10,590
+90
+0.9% +$2.47K 0.04% 219
2018
Q3
$327K Hold
10,500
0.06% 143
2018
Q2
$410K Hold
10,500
0.08% 142
2018
Q1
$290K Hold
10,500
0.06% 155
2017
Q4
$190K Hold
10,500
0.04% 188
2017
Q3
$180K Hold
10,500
0.04% 183
2017
Q2
$145K Hold
10,500
0.03% 181
2017
Q1
$161K Buy
+10,500
New +$145K 0.04% 178

Other funds holding HRTX

Venturi Wealth Management's HRTX Position: Q2 2026 in Review

Venturi Wealth Management held its Heron Therapeutics (HRTX) position steady in Q2 2026 at 10,500 shares worth $4.48K. The position accounts for ﹤0.01% of the portfolio, ranked #630.

Venturi Wealth Management first reported a position in HRTX in Q1 2017 and has held it in 24 quarters since. The position peaked at $410K in Q2 2018. 15 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • Venturi Wealth Management held 10,500 shares of Heron Therapeutics worth $4.48K as of Q2 2026.
  • Venturi Wealth Management left its Heron Therapeutics share count unchanged in Q2 2026.
  • Heron Therapeutics made up ﹤0.01% of Venturi Wealth Management's portfolio in Q2 2026, its #630 holding.
  • Venturi Wealth Management first reported a position in Heron Therapeutics in Q1 2017 and has held it in 24 quarters since.
  • Venturi Wealth Management's Heron Therapeutics position peaked at $410K in Q2 2018.
  • 15 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.